Robert Ticktin - 01 Jul 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
General Counsel & COO
Signature
/s/ Robert Ticktin
Issuer symbol
PMVP
Transactions as of
01 Jul 2025
Transactions value $
-$24,651
Form type
4
Filing time
03 Jul 2025, 19:51:53 UTC
Previous filing
23 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ticktin Robert General Counsel & COO C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON /s/ Robert Ticktin 03 Jul 2025 0001613482

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale -$24.7K -23.2K -19% $1.06 98.7K 01 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
F2 Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.